Research Topics
| Kwame Owusu-EduseiSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
|
Detail Information
Publications
Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan AfricaKwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Sex Transm Dis 38:997-1003. 2011..In this study, we compare the health and economic outcomes of the new test with existing syphilis tests/testing algorithms in a high prevalence setting...- County-level sexually transmitted disease detection and control in Texas: do sexually transmitted diseases and family planning clinics matter?Kwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Sex Transm Dis 38:970-5. 2011..However, the magnitude of their impact (or the lack thereof) has not been examined. We examine the association between having STD and/or FP clinics and county-level STD detection and control in the state of Texas... - The tale of two serologic tests to screen for syphilis--treponemal and nontreponemal: does the order matter?Kwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Sex Transm Dis 38:448-56. 2011..In this study, we analyzed the health and economic outcomes of the order of testing for the 2 serologic tests used in syphilis screening under pure screening settings... - Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007Kwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Sex Transm Dis 38:175-9. 2011..No study has directly estimated the direct outpatient medical cost of care for primary and secondary (P&S) syphilis among the employer-sponsored commercially insured population in the United States... - Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithmsKwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road MS E 80, Atlanta, GA 30333, USA
Sex Transm Dis 38:1-7. 2011..We compared the economic and health outcomes of this new algorithm with the standard algorithm from the perspective of the United States health system... - Chlamydia screening and pelvic inflammatory disease: Insights from exploratory time-series analysesKwame Owusu-Edusei
CDC, Atlanta, Georgia 30333, USA
Am J Prev Med 38:652-7. 2010..Screening for chlamydia has been reported to reduce pelvic inflammatory disease (PID) at the individual level. However, information on population-level association (or causality) is scant... - The direct cost of chlamydial infections: estimates for the employer-sponsored privately insured population in the United States, 2003-2007Kwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Sex Transm Dis 37:519-21. 2010..Estimated total cost per episode for those who were treated was $142 (male, $157; female, $141). This estimate does not include intangible cost, lost productivity, and the cost of potential sequelae... - Treatment cost of acute gonococcal infections: estimates from employer-sponsored private insurance claims data in the United States, 2003-2007Kwame Owusu-Edusei
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Sex Transm Dis 37:316-8. 2010..The estimated average total cost per episode for those who were treated was $210 (male, $227; female, $205). This estimate does not include intangible (e.g., pain) and indirect costs (e.g., lost productivity)... - Assessing the impact of state insurance policies on chlamydia screening: A panel data analysisKwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, United States
Health Policy 96:231-8. 2010..We assessed the impact of the laws on chlamydia screening rates for Georgia (GA) and Tennessee (TN)... - Using spatial regression methods to examine the association between county-level racial/ethnic composition and reported cases of Chlamydia and gonorrhea: an illustration with data from the state of TexasKwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Sex Transm Dis 36:657-64. 2009..Additionally, little is known about the relative magnitudes of the associations between county-level racial/ethnic composition and the 2 most commonly reported sexually transmitted diseases... - Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005Kwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road MS E 80, Atlanta, GA 30333, USA kowusuedusei cdc gov
Sex Transm Dis 36:395-9. 2009..Little is known about the direct medical cost and overall burden of trichomoniasis among women in the United States... - Monitoring county-level chlamydia incidence in Texas, 2004 - 2005: application of empirical Bayesian smoothing and Exploratory Spatial Data Analysis (ESDA) methodsKwame Owusu-Edusei
Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road MS E 80, Atlanta, GA 30333, USA
Int J Health Geogr 8:12. 2009..We used county-level data on chlamydia incidence (for all ages, gender and races) from the National Electronic Telecommunications System for Surveillance (NETSS) for 2004 and 2005... - A brief review of the estimated economic burden of sexually transmitted diseases in the United States: inflation-adjusted updates of previously published cost studiesHarrell W Chesson
Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
Sex Transm Dis 38:889-91. 2011..The annual direct medical cost of sexually transmitted diseases (including human immunodeficiency virus) has been estimated to be $16.9 billion (range: $13.9-$23.0 billion) in 2010 US dollars... - Synthesis and recommendations of the economic evaluation of OHS interventions at the company level conferenceElyce Biddle
Centers for Disease Control and Prevention, Division of Safety Research, National Institute for Occupational Safety Health, 1095 Willowdale Road M S 1811, 26505 Morgantown, WV, United States
J Safety Res 36:261-7. 2005.... - Examining the impact of federally-funded syphilis elimination activities in the USAHarrell Chesson
Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, GA 30333, USA
Soc Sci Med 67:2059-62. 2008..The recent increases in syphilis in the United States might have been much more pronounced had there been no syphilis elimination activities...